Influenza vaccines Vaccine safety data Main navigation COVID-19 vaccines Influenza vaccines 6 months to younger than 5 years 5 years and older (standard vaccines) 60 years and older (adjuvanted or high dose vaccine) Pregnant participants Aboriginal and Torres Strait Islander participants National Immunisation Program Schedule vaccines Mpox (monkeypox) vaccine AusVaxSafety commenced routine safety monitoring of 2023 seasonal influenza vaccines used in Australia across all ages in March 2023. The vaccines currently in use are Vaxigrip Tetra®, Fluarix Tetra®, Afluria® Quad (5 years and older), FluQuadri®, Flucelvax® Quad (2 years and older), Influvac® Tetra, Fluad® Quad (65 years and over) and Fluzone® High-Dose Quadrivalent (60 years and over). Surveillance data are provided by AusVaxSafety surveillance tools and are based on vaccine safety surveys sent in the days following influenza vaccination. AusVaxSafety surveillance of 2023 seasonal flu vaccines has concluded with no safety issues identified. Recommencement of surveillance will coincide with the release of 2024 seasonal influenza vaccines. Latest influenza vaccine safety data Click on the tiles below to view 2023 AusVaxSafety influenza vaccine safety data for specific age and population groups. Influenza vaccine safety data - 6 months to younger than 5 years View the latest safety data here Influenza vaccine safety data - 5 years and older (standard vaccines) View the latest safety data here Influenza vaccine safety data - 60 years and older (adjuvanted or high dose vaccine) View the latest safety data here Influenza vaccine safety data - Pregnant participants View the latest safety data here Influenza vaccine safety data - Aboriginal and Torres Strait Islander View the latest safety data here Vaccine safety data Main navigation COVID-19 vaccines Influenza vaccines 6 months to younger than 5 years 5 years and older (standard vaccines) 60 years and older (adjuvanted or high dose vaccine) Pregnant participants Aboriginal and Torres Strait Islander participants National Immunisation Program Schedule vaccines Mpox (monkeypox) vaccine News & events All news & events 14 September 2023 | News Vaxtracker wins Hunter New England Health Excellence Award 17 May 2023 | News Subcutaneous and intradermal administration of mpox vaccine well tolerated, AusVaxSafety study finds 10 May 2023 | News New bivalent BA.4/BA.5 COVID-19 booster vaccines well tolerated by Australians, new AusVaxSafety data show 20 April 2023 | News Influenza is back in Australia in 2023: Why a flu shot is so important, who is eligible and what to expect in the days following your vaccination